• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23886 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     Basque Office for Health Technology Assessment (OSTEBA) [Retinal protection during eye surgery]
2012     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Retigabine - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2024     National Evidence-based Healthcare Collaborating Agency (NECA) [Resuscitative endovascular balloon occlusion of the aorta]
2013     Basque Office for Health Technology Assessment (OSTEBA) [Results of the perinatal care of very premature children in the health system of the Basque Country]
2010     Andalusian Health Technology Assessment Area (AETSA) [Results from endovascular treatment in lower limb peripheral arterial disease]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Restless legs syndrome: can the symptoms be alleviated through non-medicinal procedures?]
2011     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Responder analyses for memantine in Alzheimer's disease - Rapid report]
2008     Committee for New Health Technology Assessment (CNHTA) [Respiratory syncytial virus, RT-nested PCR]
2021     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Respiratory rehabilitation following hospitalization related to a diagnosis of COVID-19]
2022     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Respiratory rehabilitation following hospitalization related to a diagnosis of COVID-19 - an update]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Respiratory polygraphy for obstructive sleep apnea syndrome]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Reslizumab (severe eosinophilic asthma) - Benefit assessment according to § 35a Social Code Book V]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Reslizumab (asthma) - Addendum to Commission A17-02]
2012     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Researchers' perceptions about the clinical and health services research call]
2011     National Evidence-based Healthcare Collaborating Agency (NECA) [Research on methodologies for evidence-based healthcare decision-making processes in Korea]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Research on medical care utilization of stroke patients and related factors in Korea]
2015     National Evidence-based Healthcare Collaborating Agency (NECA) [Research for extending the scope of health technology assessment (HTA): focusing on tobacco control]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Zemaira - congenital alpha1- antitrypsin deficiency]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Vistaseal™ – Intraoperative bleeding]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: validation of the management framework for a nonspecific human immunoglobulin shortage]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use, in Québec, of probiotics in the prevention of Clostridium difficile-associated diarrhea in hospitalized patients on antibiotic therapy]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of the SpaceOAR hydrogel rectal spacer during prostate radiotherapy]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of the prostate-specific antigen (PSA) test in prostate cancer screening in Québec]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of single-photon emission computed tomography with [ 123I]ioflupane (DaTscan) in the diagnostic process for parkinsonian syndromes]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of platelet-rich plasma for the treatment of knee osteoarthritis]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of placental growth factor (PlGF) testing in suspected preeclampsia]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of microsurgery for the prevention and treatment of cancer-related lymphedema]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of linear accelerators with on-board magnetic resonance imaging (MRI) for real-time MRI-guided radiation therapy treatments]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of extracorporeal membrane oxygenation (ECMO) in adults in Quebec]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of clinical data from electronic medical records for research and continuous quality improvement in front-line care and services]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: treatment of mitral regurgitation by a percutaneous device with clip (TMVRc)]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tisagenlecleucel for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: the use of EndoPredict and Prosigna for early invasive breast cancer]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: the therapeutic value of hyperbaric oxygen (HBO) on children with cerebral palsy]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: the placenta, utility of and indications for the transfer of samples to the anatomical pathology laboratory for analysis]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: The Argus II retinal implant]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Takhzyro (lanadelumab), notice of inclusion on the Liste des produits du système du sang du Québec]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: surgical treatment of the esophagus - quality and accessibility in Quebec]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: submission of surgical specimens to the anatomic pathology laboratory: relevance and indications - vascular, cardiovascular and thoracic surgery]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: submission of surgical specimens to the anatomic pathology laboratory: relevance and indications - otolaryngology and oral, maxillofacial and head and neck surgery]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: submission of surgical specimens to the anatomic pathology laboratory: relevance and indications - eye surgery]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: submission of surgical specimens to the anatomic pathology laboratory - relevance and indications - orthopedic surgery and neurosurgery]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: statins, lipid-lowering agents and cardiovascular risk reduction]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: setting safety and conditions for success of vaginal birth after cesarean]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: revision of criteria for the withholding and termination of resuscitation by paramedics in prehospital setting]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: resuscitation in community opioid overdose ‒ update and complement to INESSS guidance published in 2018 - Cardiopulmonary resuscitation (CPR) in a context of community-based naloxone administration for opioid overdose]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevant practices for promoting hearing health in long-term residential care settings]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of using mpMRI for the diagnostic investigation of prostate cancer - mpMRI and prostate cancer diagnosis]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of neonatal pulse oximetry screening for critical congenital heart disease]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of low-dose computed tomography lung cancer screening]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of introducing a pathogen inactivation process for labile blood products in Quebec]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of and indications for submitting surgical specimens to the anatomic pathology laboratory: obstetrics/gynecology and urology]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of and indications for submitting surgical specimens to the anatomic pathology laboratory: general surgery, plastic surgery and dermatology]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of adding universal screening for congenital cytomegalovirus (CMV) infection to Québec newborn screening program]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of adding two genetic variants of Zellweger spectrum disorder to the carrier testing offer for people from the Saguenay-Lac-Saint-Jean, Charlevoix, and Haute-Côte-Nord regions]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of adding the HbS/E, HbE/E and HbE/β-thal variants to the primary targets of the neonatal screening test for hemoglobinopathies]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of adding newborn screening for congenital adrenal hyperplasia to the Quebec newborn blood screening program]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of adding a genetic variant of mucolipidosis type II to the carrier testing offer for people from the Saguenay-Lac-Saint-Jean, Charlevoix, and Haute-Côte-Nord regions]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: reducing the carbon footprint of anesthetic agents inhaled in the operating room during general anesthesia - strategies and challenges to consider]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: recommendations concerning the information required to monitor nusinersen use in real-world settings]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: RebinynTM (nonacog beta pegol) – coagulation factor IX (recombinant), notice of inclusion on the Liste des produits du système du sang du Québec]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Rebinyn (nonacog beta pegol) – Type B hemophilia (re-evaluation)]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Rebinyn – prophylaxis in children and adolescents with hemophilia B]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: quantification of antipsychotics in serum using high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS)]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: psychosocial interventions in youth aged under 18 with attention deficit/hyperactivity disorder (ADHD)]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Prolastin-C Liquid – congenital alpha1-antitrypsin deficiency]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: plasma sC5b-9 assay]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: pertussis - diagnostic modalities and trajectory]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: perineal and pelvic rehabilitation for the prevention and treatment of pelvic floor dysfunctions – Part 1: Urinary incontinence]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: perineal and pelvic rehabilitation for the prevention and treatment of pelvic floor dysfunctions - Part 2: Anorectal dysfunction, pelvic organ prolapse and perineal pain in women]
2017     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: organization of the continuum and provision of services to children aged 2 to 9 years with specific language impairment]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Optune - for the treatment of adult patients with newly diagnosed glioblastoma]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: optimal use of immunoglobulins in rheumatology. Report in support of the optimal use guide English summary]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: optimal service trajectory for children, adolescents and young adults with attention deficit disorder with or without hyperactivity (ADHD) or related problems]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: optimal modalities for organizing and delivering care and services related to radical cystectomy in Quebec]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: optical genome mapping - diagnosis and prognostic stratification of hematological malignancies]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: noninvasive fetal RhD genotyping using maternal plasma]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: NK cell degranulation (natural killer)]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: NGAL assay for the detection of acute kidney injury]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: microbiological stool testing in adults and children with diarrhea: relevance and measures to promote judicious use]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: linezolid plasma dosing]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: KIT D816V mutation detection by NAAT]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: KamRAB (human rabies immunoglobulin) – passive and transient postexposure prophylaxis of rabies infection]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: judicious use of medical biology tests in the diagnosis and treatment of Helicobacter pylori infection]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: iStent® and iStent inject® trabecular bypass for micro-invasive glaucoma surgery (MIGS)]
2018     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: islet transplantation in patients with unstable type I diabetes]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: intensive outpatient services for youths with psychoactive substance use disorders]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: indications justifying the use of imaging for diagnosing patients with primary or secondary headache]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: immunoglobulin shortage: alternative treatments to nonspecific human immunoglobulins]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: high-dose vitamin C injections for cancer patients in Quebec]
2019     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: HemlibraMC (emicizumab) - Hemophilia A, notice of inclusion on the Liste des produits du système du sang du Québec]
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Hemlibra (emicizumab) – Hemophilia A without inhibitor (re evaluation)]
2023     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Glassia – congenital alpha1- antitrypsin deficiency]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: expressing wishes regarding goals of care and the decision about cardiopulmonary resuscitation]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: evaluation of the relevance of newborn screening for severe combined immunodeficiency SCID]
2022     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: evaluation of Synvisc and Synvisc One for the management of knee osteoarthritis]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: evaluation of STAT1 phosphorylation status by flow cytometry]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: evaluation of intensive behavioural intervention (EIBI) for preschool-age autistic children in Québec]